Related Experiment Videos
Enterococci acquire new kinds of resistance
1Service de Bactériologie-Virologie-Hygiène, Hôpital Henri Mondor, Université Paris XII, Créteil, France.
Summary
Enterococci exhibit increasing antimicrobial resistance, including to aminoglycosides, penicillins, and glycopeptides. This resistance poses significant clinical challenges, with some strains becoming resistant to all available antibiotics.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Enterococci are a growing cause of nosocomial infections.
- Increasing antimicrobial resistance in enterococci presents significant clinical challenges.
- High-level resistance to multiple antibiotic classes has been documented.
Purpose of the Study:
- To review the mechanisms and clinical implications of antimicrobial resistance in enterococci.
- To highlight the emergence of multidrug-resistant enterococcal strains.
- To discuss the impact of resistance on treatment strategies.
Main Methods:
- Literature review of antimicrobial resistance mechanisms in enterococci.
- Analysis of clinical implications of antibiotic resistance.
- Discussion of resistance transfer mechanisms.
Main Results:
- Enterococci show high-level resistance to aminoglycosides, penicillins, and glycopeptides.
- Mechanisms include altered penicillin-binding proteins, beta-lactamase production, and enzyme modification.
- Plasmid-mediated glycopeptide resistance has epidemic potential, transferable to other bacteria like Staphylococcus aureus.
Conclusions:
- Antimicrobial resistance in enterococci is a critical public health concern.
- Understanding resistance mechanisms is vital for effective treatment and infection control.
- The spread of resistance genes, particularly on plasmids, necessitates vigilant surveillance and intervention.